NCT05582434 — drugset

Summary

Acne is a chronic condition that typically requires the use of multiple medications.1 Medication adherence is especially challenging for patients with chronic diseases and often decreases over time, especially for those using topical medications.1 Nonadherence can result in multiple negative effects including treatment failure, increased healthcare costs, and decreased quality of life. Primary nonadherence refers to problems acquiring and starting treatment. Challenges to this form of nonadherence include a lack of knowledge, misunderstanding of usage, poor communication with provider, increased cost, and fear of side effects.2 Secondary nonadherence refers to when the patient does not use the medication as prescribed. Hurdles to secondary nonadherence include delayed results, increased complexity of treatment plan, adverse effects, busy lifestyle, and inconvenience.2

Timeline

Start: 2024-02-15
Primary completion: 2025-06-19
Completion: 2026-11

Publications

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Adapalene	Other / unclassified	0.1 %	Topical
Subject	BPO	Unknown	2.5 %	Topical
Subject	Clindamycin	Unknown	1.2 %	Topical
Subject	Epiduo® Forte	Unknown	0.3 %	Topical
Subject	Epiduo® Forte	Unknown	2.5 %	Topical
Subject	clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel	Unknown	0.15 %	Topical
Subject	clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel	Unknown	1.2 %	Topical
Subject	clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel	Unknown	3.1 %	Topical

Experience With Topical Acne Treatment

Summary

Timeline

Publications

Drugs

Indications